Caudal ear nerve stimulation to test gut movement in healthy adults
Official title: The Effect of Non-invasive Transauricular Vagus Nerve Stimulation on Upper Gastrointestinal Motility in Healthy Individuals
Run by Academisch Ziekenhuis Maastricht · NCT07632378 · Data updated 2026-11-12
This study tests whether transcutaneous auricular vagus nerve stimulation can influence upper gastrointestinal movement in healthy adults who participate in a randomised, crossover setup.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 55 Years |
| Sex | All |
| Enrollment | 12 (estimated) |
| Sponsor | Academisch Ziekenhuis Maastricht Academic / other |
| Locations | 1 site (Maastricht, Limburg) |
| Status | Recruiting |
| Started | February 25, 2025 |
| Main results expected | June 2026 |
| Study ends | June 2026 |
| Registry record updated | June 8, 2026 |
| Trial ID | NCT07632378 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy adults aged 18-55 without GI or cardiac conditions and who can understand Dutch.
✕Probably not a fit
Participants with pre-existing GI disorders, cardiac arrhythmias, pregnancy, or substances affecting GI motility may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, randomized crossover trial evaluates the effects of transcutaneous auricular vagus nerve stimulation (tVNS) on upper gastrointestinal motility in healthy adults. Participants undergo 8 hours of upper GI motility recording with manometry while receiving either active tVNS or sham stimulation in random order. Secondary measures include duodenal phase III contractions, gastric and duodenal MMCs, antral contraction amplitude, motility index, motilin and peptide YY levels, autonomic markers, and comparison with Gastric Alimetry data. The study uses standard safety procedures, screening, and imaging guidance for catheter placement, with data managed in Castor EDC at Maastricht University Medical Center.
Why it matters
Potential benefit: If successful, tVNS could become a non-drug option to modulate gut motility in ways that could inform future therapies.
How similar studies have gone: Previous research on neuromodulation and GI motility shows potential but this specific tVNS and antroduodenal motility crossover approach is newer.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy participants (defined as those without a pre-existing medical comorbidity, including those without a history of cardiac arrhythmia). * Age between 18 and 55 years. * Ability to understand and speak the Dutch language. Exclusion Criteria: * Pregnancy or lactation. * Use of any substances (such as medication or recreational drugs) influencing gastrointestinal motility * Not meeting the inclusion criteria above. * Students and employees of Maastricht University are not precluded from participation, unless they have a direct personal, professional of hierarchical position with regards to any of the study team members or their department.
Where it's running
-
Maastricht University
Maastricht, Limburg, Netherlands Recruiting
Study contacts
- Principal investigator: Daniel Keszthelyi, MD, PhD — Maastricht University Medical Center
- Study coordinator: Kimberly Hawinkels, MD
- Email: kimberly.hawinkels@maastrichtuniversity.nl
- Phone: +31883887808
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How age affects germinal center responses after flu and rabies vaccines
Researchers will test how the immune system responds to flu and rabies vaccines in younger adults (18–40) and older adults (65+).
-
Magnetic field maps with NV sensors for non-invasive heart measurements
This study tests whether diamond-based NV magnetometers can non-invasively detect and map the heart's magnetic field in healthy adults.
-
Methylation analyses using home-based self-sampling in women with and without gynecological disease
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation markers that distinguish people with gynecological (pre-)cancers from cancer-free controls.
-
Omega-3 status in healthy adults: comparing different fish-oil and algae-oil products
This study tests whether various fish-oil and algae-oil products can raise the Omega-3 Index in healthy adults who don’t eat much fatty fish.
-
A safe, carefully dosed test of TBD11 in healthy adults
This phase 1 study tests TBD11 in healthy adults to see if it is safe and tolerable and to understand how it behaves in the body, including how it interacts with other medicines.
-
Fosmanogepix in healthy adults: how it may interact with other drugs and heart rhythm
This study tests whether fosmanogepix (and its active form manogepix) changes how other medicines work in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.